Skip to main content

Table 1 Overview of previous cases of extremity tuberculous muscle abscess reported in the literature

From: Diagnosis of multiple tuberculous muscle abscesses in a patient with systemic lupus erythematosus by metagenomic next-generation sequencing- a case report and literature review

Case

Gender

Age (year)

Infection sites

Duration

Underlying diseases

Complicated with PTB

Treatment options

Treatment outcome

References

 

1

Female

45

Left thigh

3 moinths

NA

No

HRZE + puncture

Improved

[6]

 

2

Male

83

Left lower leg

NA

Addison’s disease & Paget’s disease

No

HRZ

Cured

[7]

 

3

Male

45

Right palm

2 weeks

Kidney transplantation

Yes

HRZ

Cured

[8]

 

4

Male

0.9

Left thigh

8 months

NA

No

HRZE/HR

Cured

[9]

 

5

Female

41

Left forearm

6 months

NA

No

HRZE

Cured

[10]

 

6

NA

0.5

Thigh

NA

NA

No

Antituberculosis drugs

Cured

[11]

 

7

Male

62

Right thigh

12 months

Total hip arthroplasty

No

Antituberculosis drugs

Cured

[12]

 

8

Male

52

Left thigh

6 months

Dermatomyositis

No

HRZE

Cured

[13]

 

9

Male

48

Left thigh

2 months

NA

No

HRZ + puncture

Cured

[14]

 

10

Male

46

Right upper arm

10 days

Dermatomyositis

No

Isoniazid + rifampin + ethambutol + moxifloxacin

NA

[15]

 

11

Male

71

Right thigh

2 months

Lymphatic tuberculosis

No

HRZE + drainage

Cured

[15]

 

12

Female

46

Right thigh

1 month

SLE and APS

No

HRZE + drainage

Cured

[15]

 

13

Male

11

Right upper arm

2 months

NA

No

HRZE + drainage

Cured

[16]

 

14

Male

2

Right lower leg

1.5 months

Upper respiratory tract infection

No

HRZE/HRE

Cured

[17]

 

15

          

16

Female

21

Right thigh

1 month

NA

No

HRZE/HR

Cured

[18]

 

17

Male

47

Left upper arm and left thigh

1 month

Dermatomyositis

No

HRZE + drainage + streptomycin injection

Cured

[19]

 

18

Male

25

Back

3 months

NA

 

HRZE

Cured

[20]

 

19

Female

47

Right upper arm

NA

NA

No

HRZE

Cured

[21]

 
  1. HRZE, fixed-dose combination with isoniazid(H)-rifampicin(R)-ethambutol(E)-pyrazinamide(Z);SLE, systemic lupus erythematosus; APS, antiphospholipid syndrome; PTB, pulmonary tuberculosis; NA, not applicable